•What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol
•FOLFOX-based transarterial infusion chemotherapy for unresectable colorectal cancer: protocol of an open-label, multicentre, randomised, controlled, phase II trial
•Clinical heterogeneity and disease progression during adolescence in AGPAT2-associated congenital generalized lipodystrophy: a case series of four patients
•Clinicopathological analyses of nephrotic syndrome after liver transplantation
•Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched study
